Dr. Thomas W. Ratliff, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Southwestern Medical School at Dallas (1987)
- Years since graduation
- 39
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,226
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1987Medical school: University of Texas Southwestern Medical School at Dallas
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
TN license 31689 · AR license E3185 · MS license 14362
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Methodist Hospitals of Memphis Memphis, TN
- Baptist Memorial Hospital Memphis, TN
- Regional One Health Memphis, TN
- St Francis Hospital Memphis, TN
- Saint Francis Bartlett Medical Center Bartlett, TN
Medical groups
- The West Clinic P.c. (118 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,226
- Services billed
- 99,398
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 2,036 | 546 |
| Blood test, basic group of blood chemicals (calcium, total) | 1,783 | 536 |
| Liver function blood test panel | 1,689 | 534 |
| Flow cytometry technique for dna or cell analysis, each additional marker | 1,409 | 57 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,378 | 295 |
| Insertion of needle into vein for collection of blood sample | 1,349 | 440 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,049 | 448 |
| Vitamin d-3 level | 456 | 327 |
| Gammaglobulin (immune system protein) measurement | 426 | 82 |
| Ferritin (blood protein) level | 394 | 231 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Potassium Chloride Other prescribers in Germantown, TN | 205 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Germantown, TN | 199 |
| Eliquis (apixaban) Other prescribers in Germantown, TN | 178 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Germantown, TN | 176 |
| Oxycodone Hcl Other prescribers in Germantown, TN | 153 |
| Gabapentin Other prescribers in Germantown, TN | 149 |
| Alprazolam Other prescribers in Germantown, TN | 147 |
| Ondansetron Odt (ondansetron) Other prescribers in Germantown, TN | 129 |
| Xarelto (rivaroxaban) Other prescribers in Germantown, TN | 103 |
| Anastrozole Other prescribers in Germantown, TN | 95 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 45 payments worth $3,376 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $1,696 |
|---|---|
| Daiichi Sankyo Inc. | $723 |
| Gilead Sciences, Inc. | $155 |
| Beone Medicines USA, Inc. | $147 |
| Astellas Pharma US Inc | $91.29 |
| AbbVie Inc. | $77.94 |
| Novartis Pharmaceuticals Corporation | $71.04 |
| Pfizer Inc. | $51.88 |
| Consulting Fee | $2,325 |
|---|---|
| Food and Beverage | $976 |
| Education | $74.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Dec 15, 2025 | Consulting Fee IMFINZI · Oncology | $1,675 |
| Daiichi Sankyo Inc. Sep 22, 2025 | Consulting Fee Vanflyta · ONCOLOGY | $650 |
| Astellas Pharma US Inc Jun 18, 2025 | Education in-kind | $74.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.